The beta-hCG+erythropoietin in acute stroke (BETAS) study: a 3-center, single-dose, open-label, noncontrolled, phase IIa safety trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples